Clinical Trials Directory

Trials / Unknown

UnknownNCT04766619

Process Evaluation of OptimiseRx and PINCER

Generating Recommendations for National Roll-out and Sustainable Use of Prescribing Safety Indicator Based Interventions Using Longitudinal Process Evaluation and a Consolidated Learning Exercise

Status
Unknown
Phase
Study type
Observational
Enrollment
390 (estimated)
Sponsor
University of Nottingham · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This study aims to evaluate two interventions designed to make medication prescribing safer, OptimiseRx and PINCER, which are being used in general practices across England. The findings from the evaluation will be used to generate recommendations as to how these interventions can be used sustainably in the long-term.

Detailed description

This study has been designed to evaluate and gain an understanding of the 'real world' implementation, fidelity and medium and longer-term embedding and sustainability of two prescribing safety interventions: the computerised decision support (CDS) tool - Optimize Rx, and PINCER (pharmacist-led information technology intervention for reducing clinically important errors in medication management). The longitudinal process evaluation will involve observations, interviews, focus groups and questionnaires. The consolidated learning exercise, which aims to inform long-term, sustainable intervention use will involve a documentary analysis, interviews, focus groups, development workshops and a synthesis of the evaluation results.

Conditions

Timeline

Start date
2018-02-16
Primary completion
2021-08-31
Completion
2023-02-28
First posted
2021-02-23
Last updated
2021-02-23

Locations

3 sites across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT04766619. Inclusion in this directory is not an endorsement.